RealTimeTouch.com RealTimeTouch.com Patent US9639150 RealTimeTouch.com message RealTimeTouch.com RealTimeTouch.com



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




RealTimeTouch.com RealTimeTouch.com Patent US9639150 RealTimeTouch.com message RealTimeTouch.com RealTimeTouch.com

Similar
Filing Names

Pharmacyclics Inc
Pharmacyclics Inc A Delaware Corporation
Pharmacyclics Inc_20100128
Pharmacyclics Inc_20100107
  

Pharmacyclics Inc patents

Recent patent applications related to Pharmacyclics Inc. Pharmacyclics Inc is listed as an Agent/Assignee. Note: Pharmacyclics Inc may have other listings under different names/spellings. We're not affiliated with Pharmacyclics Inc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "P" | Pharmacyclics Inc-related inventors




Date Pharmacyclics Inc patents (updated weekly) - BOOKMARK this page
11/26/15Combinations of histone deacetylase inhibitor and pazopanib and uses thereof
11/12/15Novel hydroxamates as therapeutic agents
11/12/15Selective inhibitors of histone deactylase
11/05/15New salt of abexinostat, associated crystalline form, a process for their preparation and pharmaceutical compositions containing them
10/29/15Inhibitors of bruton's tyrosine kinase
10/29/15Inhibitors of bruton's tyrosine kinase
10/22/15Indole derivatives as inhibitors of histone deacetylase
10/15/15Intracellular kinase inhibitors
09/24/15Inhibitors of bruton's tyrosine kinase
09/24/15Phospholipase c gamma 2 and resistance associated mutations
09/17/15Companion diagnostics for tec family kinase inhibitor therapy
08/27/15Biomarkers for predicting response of dlbcl to treatment with ibrutinib
08/27/15Pyrrolopyrimidine compounds as kinase inhibitors
07/02/15Mutations associated with resistance to inhibitors of bruton's tyrosine kinase (btk)
06/18/15Formulations of histone deacetylase inhibitor and uses therof
06/11/15Methods of treating and preventing alloantibody driven chronic graft versus host disease
06/11/15Inhibitors of bruton's tyrosine kinase
06/11/15Crystalline forms of a bruton's tyrosine kinase inhibitor
06/04/15Inhibitors of bruton's tyrosine kinase
05/21/15Methods for delaying or preventing the onset of type 1 diabetes
05/14/15Inhibitors of bruton's tyrosine kinase
04/30/15Methods of treating and preventing graft versus host disease
04/30/15Treatment using bruton's tyrosine kinase inhibitors and immunotherapy
04/23/15Inhibitors of bruton's tyrosine kinase
04/02/15Inhibitors of bruton's tyrosine kinase
02/12/15Methods for the treatment of her2 amplified cancer
02/12/15Cinnamic acid hydroxyamides as inhibitors of histone deacetylase 8
02/05/15Association between n-hydroxy-4-benzamide and folfox
02/05/15Methods for the treatment of solid tumors
02/05/15Uses of selective inhibitors of hdac8 and treatment of inflammatory conditions
01/29/15Use of inhibitors of bruton's tyrosine kinase (btk)
01/29/15Use of inhibitors of bruton's tyrosine kinase (btk)
01/22/15Administration regime for n-hydroxy-4-benzamide
01/15/15Pyrazolo[3,4-d]pyrimidine and pyrazolo[2,3-d]pyrimidine compounds as kinase inhibitors
12/25/14Purinone compounds as kinase inhibitors
12/25/142-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors
12/18/14Tec family kinase inhibitor adjuvant therapy
11/20/14Formulations of histone deacetylase inhibitor in combination with bendamustine and uses thereof
09/18/14Inhibitors of bruton's tyrosine kinase
08/28/14Inhibitors of bruton's tyrosine kinase
08/07/14Factor viia inhibitor
07/31/14Inhibitors of bruton's tyrosine kinase
07/10/14Use of inhibitors of bruton's tyrosine kinase (btk)
07/03/14Inhibitors of bruton's tyrosine kinase
07/03/14Inhibitors of bruton's tyrosine kinase
06/19/14Inhibitors of bruton's tyrosine kinase
06/12/14Inhibitors of bruton's tyrosine kinase
06/12/14Inhibitors of bruton's tyrosine kinase
05/22/14Inhibitors of bruton's tyrosine kinase
05/22/14Pyrrolopyrimidine compounds as kinase inhibitors
05/15/14Tec family kinase inhibitor adjuvant therapy
05/15/14Inhibitors of bruton's tyrosine kinase
05/08/14Inhibitors of bruton's tyrosine kinase
05/08/14Inhibitors of bruton's tyrosine kinase
03/20/14Inhibitors of bruton's tyrosine kinase for the treatment of solid tumors
03/20/14Inhibitors of bruton's tyrosine kinase
03/20/14Factor viia inhibitor
02/27/14Formulations of histone deacetylase inhibitor and uses therof
02/27/14Inhibitors of bruton's tyrosine kinase
02/06/14Manufacture, compositions and uses of coagulation factor viia modulator
02/06/14Inhibitors of bruton's tyrosine kinase
01/02/14Selective inhibitors of histone deacetylase
12/19/13Crystalline forms of a bruton's tyrosine kinase inhibitor
11/21/13Use of inhibitors of bruton's tyrosine kinase (btk)
10/17/13Use of inhibitors of bruton's tyrosine kinase (btk)
Patent Packs
08/29/13Bruton's tyrosinie kinase activity probe and using
08/08/13Use of inhibitors of bruton's tyrosine kinase (btk)
08/01/13Use of inhibitors of bruton's tyrosine kinase (btk)
08/01/13Purinone compounds as kinase inhibitors
07/11/13Methods and compositions for inhibition of bone resorption
07/04/13Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors
06/20/13Indole derivatives as inhibitors of histone deacetylase
06/20/132-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors
06/20/13High-purity texaphyrin metal complexes
06/20/13Manufacture, compositions and uses of coagulation factor viia modulator
06/06/13Novel hydroxamates as therapeutic agents
03/28/13Uses of selective inhibitors of hdac8 for treatment of inflammatory conditions
02/07/13Inhibitors of bruton's tyrosine kinase
01/17/13Inhibitors of bruton's tyrosine kinase
01/17/13Inhibitors of bruton's tyrosine kinase
Patent Packs
01/03/13Inhibitors of bruton's tyrosine kinase
01/03/13Inhibitors of brutons tyrosine kinase for the treatment of solid tumors
12/27/12Inhibitors of bruton's tyrosine kinase
11/22/12Inhibitors of bruton's tyrosine kinase
11/08/12Inhibitors of bruton's tyrosine kinase
11/08/12Inhibitors of bruton's tyrosine kinase
11/01/12Inhibitors of bruton's tyrosine kinase
11/01/12Inhibitors of bruton's tyrosine kinase
11/01/12Inhibitors of bruton's tyrosine kinase
10/04/12Inhibitors of bruton's tyrosine kinase
10/04/12Inhibitors of bruton's tyrosine kinase
08/23/12Inhibitors of bruton's tyrosine kinase
08/09/12Inhibitors of il2-inducible t-cell kinase
07/19/12Use of inhibitors of bruton's tyrosine kinase (btk)
07/19/12Inhibitors of bmx non-receptor tyrosine kinase
07/19/12Inhibitors of bruton's tyrosine kinase
07/12/12Inhibitors of bruton's tyrosine kinase
06/28/12Inhibitors of b lymphocyte kinase
05/31/12Inhibitors of bruton's tyrosine kinase
05/24/12Inhibitors of bruton's tyrosine kinase
05/24/12Inhibitors of bruton's tyrosine kinase
05/17/12Inhibitors of bruton's tyrosine kinase
05/10/12Inhibitors of bruton's tyrosine kinase
05/03/12Inhibitors of tyrosine kinases and uses thereof
05/03/12Inhibitors of bruton's tyrosine kinase
04/26/12The use of inhibitors of bruton's tyrosine kinase (btk)
04/26/12Inhibitors of tyrosine kinases and uses thereof
04/26/12Inhibitors of bruton's tyrosine kinase
04/26/12Inhibitors of bruton's tyrosine kinase
04/19/12Inhibitors of bruton's tyrosine kinase
Social Network Patent Pack
04/12/12Use of inhibitors of bruton's tyrosine kinase (btk)
04/12/12Inhibitors of bruton's tyrosine kinase
04/05/12Inhibitors of tyrosine kinases and uses thereof
03/22/12Methods of treating abc-dlbcl using inhibitors of bruton's tyrosine kinase
03/15/12Novel hydroxamates as therapeutic agents
03/15/12Inhibitors of bruton's tyrosine kinase
03/01/12Btk inhibitors for the treatment of immune mediated conditions
12/22/11Formulations of histone deacetylase inhibitor and uses thereof
11/17/11Inhibitors of bruton's tyrosine kinase
11/03/112-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors
Patent Packs
09/15/11Inhibitors of bruton's tyrosine kinase for the treatment of solid tumors
08/25/11Factor viia inhibitor
07/28/11Inhibitors of bruton's tyrosine kinase
06/23/11Uses of selective inhibitors of hdac8 for treatment of inflammatory conditions
04/14/11Inhibitors of bruton's tyrosine kinase
03/03/11Methods for determining cancer resistance to histone deacetylase inhibitors
02/24/11Texaphyrin solutions and pharmaceutical formulations
02/17/11Inhibitors of bruton's tyrosine kinase
01/27/11Novel hydroxamates as therapeutic agents
01/13/11Inhibitors of bruton's tyrosine kinase
12/30/10Inhibitors of bruton's tyrosine kinase
11/25/10Manufacture, compositions and uses of coagulation factor viia modulator
11/11/10Calcium flux as a pharmacoefficacy biomarker for inhibitors of histone deacetylase
02/25/10High-purity texaphyrin metal complexes
02/18/10Inhibitors of bruton's tyrosine kinase
02/11/10Inhibitors of tyrosine kinases and uses thereof
01/28/10Inhibitors of bruton's tyrosine kinase
01/07/10Inhibitors of bruton's tyrosine kinase
10/29/09Treatment of non-localized inflammation with pan-hdac inhibitors
09/03/09Novel hydroxamates as therapeutic agents
08/06/09Methods and compositions of treating cancer
07/16/09Inhibitors of brutons tyrosine kinase
05/14/09Methods for determining cancer resistance to histone deacetylase inhibitors
01/28/10Inhibitors of bruton's tyrosine kinase
01/07/10Inhibitors of bruton's tyrosine kinase
12/23/10Inhibitors of bruton's tyrosine kinase







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Pharmacyclics Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Pharmacyclics Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';